Citywire for Financial Professionals

BB Healthcare Trust (Ordinary Share) BBH

Sector Specialist: Biotechnology/Life Sciences

Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Add to Virtual Portfolio | Print page

Estimated NAV


Share Price


Total Returns on £1000 over 

Fund / Benchmark Total returns(%)
BB Healthcare Trust (Ordinary Share) Price 11.55%
BB Healthcare Trust (Ordinary Share) NAV 13.94%
FTSE World 13.37%
Total Returns on £1000

Discount / Premium Movement

Discount / Premium Movement


Share Type Yesterday's
Closing Price
Discount / Premium Diluted NAV Gearing Dividend
Est Last
Ordinary Share 118.5 2.2% 116.00 116.00
19 Jan

Discrete performance % over

Fund / BenchmarkQ1Q2Q3Q4
BB Healthcare Trust (Ordinary Share) Price11.55
BB Healthcare Trust (Ordinary Share) NAV13.94
FTSE World13.37

Discrete performance over

Discrete Performance

Top 10 Holdings

Align Technology, Inc. 7.40%
Anthem 6.20%
Walgreens Boots Alliance Inc 5.30%
Amgen Inc 5.20%
Eli Lilly & Co. 5.00%
Celgene Corporation 4.70%
Intuitive Surgical, Inc. 4.50%
Shire PLC 4.13%
Illumina, Inc. 4.00%
AmerisourceBergen Corp 3.90%

Sectors weighting

Healthcare 100.00%

Regional weighting

North America Region 91.00%
UK 6.00%
Europe Developed ex-UK 3.00%
  • Investment trust info:

  • Sector Sector Specialist: Biotechnology/Life Sciences
  • Launch Date 02 Dec 2016
  • Currency GBX
  • Domicile UK
  • Share Price N/A
  • Share Type Ordinary Share
  • Shares Issued (M) 262
  • Market Capital (£M) 310.91
  • Gross Assets (£M) 316.59
  • Net Assets (£M) 304.15
  • TER (%)  
  • Last AGM  
  • Next AGM  
  • Last Annual Report Date  
  • Next due Report Date  
  • Next due Report Type I/R
  • Objective:

  • To provide Shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies.
  • Management Group(s):

  • Bellevue Asset Management
  • Managed by:

  • Daniel Koller Start: 02 Dec 2016
  • Paul Major Start: 02 Dec 2016
  • Management Contract & Fees:

    The Investment Manager is entitled to a management fee together with reimbursement of reasonable expenses incurred by it in the performance of its duties. The management fee is payable monthly in arrear and is at the rate of one-twelfth of 0.95% per calendar month of the Market Capitalisation. The agreement is terminable on 12 months' notice.

Sorry, this link is not
quite ready yet